COMMUNITY-ORIENTED.. SCIENCE-FOCUSED

Highlighting the Kingdom’s leadership vision, LFB Arabia is the fruit of the first Public Private Partnership (PPP) model in the pharmaceutical field in the Kingdom for such an advanced industry. It is another strategic partnership with a major European player in the therapeutic protein field, French LFB S.A. The group is the leading manufacturer of plasma-derived medicinal products in France and 5th worldwide. It is also among the leading European companies for the development of new-generation medicinal products based on biotechnologies.

 

LFB Arabia is partnering with the government of Saudi Arabia to establish a state-of-the art human plasma fractionation plant. The process of extracting human plasma blood derivatives is the first of its kind in the Kingdom of Saudi Arabia and the whole Muslim world. This ambitious plan benefits from the vast knowledge of the French LFB and allows their expertise to shape each step it takes in the advanced pharmaceutical and biotechnological field.

OUR INFO

NEWSLETTER

 

 

Subscribe  to  our  newsletter  to  get  the latest  updates  and  company  news

Submitting Form...

The server encountered an error.

Form received.

All Rights Reserved © 2016 | Healthcare Development Holding Company (HDH)

ABOUT US

 

 

Healthcare Development Holding  (HDH)  Company was formed in November  2008  with  the  objective  of developing  and  providing a wide range of  healthcare  services  while  focusing on building   local  expertise. HDH plans  to achieve its goals through the strength of its experienced local staff and international partners.

OUR INFO

NEWSLETTER

 

 

Subscribe  to  our  newsletter  to  get  the latest  updates  and  company  news

Submitting Form...

The server encountered an error.

Form received.

All Rights Reserved © 2016 | Healthcare Development Holding Company (HDH)

ABOUT US

 

 

Healthcare Development Holding  (HDH)  Company was formed in November  2008  with  the  objective  of developing  and  providing a wide range of  healthcare  services  while  focusing on building   local  expertise. HDH plans  to achieve its goals through the strength of its experienced local staff and international partners.

COMMUNITY-ORIENTED.. SCIENCE-FOCUSED

Highlighting the Kingdom’s leadership vision, LFB Arabia is the fruit of the first Public Private Partnership (PPP) model in the pharmaceutical field in the Kingdom for such an advanced industry. It is another strategic partnership with a major European player in the therapeutic protein field, French LFB S.A. The group is the leading manufacturer of plasma-derived medicinal products in France and 5th worldwide. It is also among the leading European companies for the development of new-generation medicinal products based on biotechnologies.

 

LFB Arabia is partnering with the government of Saudi Arabia to establish a state-of-the art human plasma fractionation plant. The process of extracting human plasma blood derivatives is the first of its kind in the Kingdom of Saudi Arabia and the whole Muslim world. This ambitious plan benefits from the vast knowledge of the French LFB and allows their expertise to shape each step it takes in the advanced pharmaceutical and biotechnological field.

ABOUT US

 

 

Healthcare  Development  Holding   (HDH)  Company was formed  in  November  2008  with  the  objective  of developing  and  providing a wide range of  healthcare  services  while  focusing  on  building   local  expertise. HDH  plans  to  achieve  its  goals  through  the  strength of  its  experienced  local  staff   and   international   partners.

NEWSLETTER

 

 

Subscribe  to  our  newsletter  to  get  the latest  updates  and  company  news

Submitting Form...

The server encountered an error.

Form received.

OUR INFO

All Rights Reserved © 2016 | Healthcare Development Holding Company (HDH)

OUR INFO

ABOUT US

 

 

Healthcare  Development  Holding   (HDH)  Company was formed  in  November  2008  with  the  objective  of developing  and  providing a wide range of  healthcare  services  while  focusing  on  building   local  expertise. HDH  plans  to  achieve  its  goals  through  the  strength of  its  experienced  local  staff   and   international   partners.

All Rights Reserved © 2016 | Healthcare Development Holding Company (HDH)

NEWSLETTER

 

 

Subscribe  to  our  newsletter  to  get  the latest  updates  and  company  news

Submitting Form...

The server encountered an error.

Form received.

OUR INFO

ABOUT US

 

 

Healthcare  Development  Holding   (HDH)  Company was formed  in  November  2008  with  the  objective  of developing  and  providing a wide range of  healthcare  services  while  focusing  on  building   local  expertise. HDH  plans  to  achieve  its  goals  through  the  strength of  its  experienced  local  staff   and   international   partners.

All Rights Reserved © 2016 | Healthcare Development Holding Company (HDH)

NEWSLETTER

 

 

Subscribe  to  our  newsletter  to  get  the latest  updates  and  company  news

Submitting Form...

The server encountered an error.

Form received.

OUR INFO

ABOUT US

 

 

Healthcare  Development  Holding   (HDH)  Company was formed  in  November  2008  with  the  objective  of developing  and  providing a wide range of  healthcare  services  while  focusing  on  building   local  expertise. HDH  plans  to  achieve  its  goals  through  the  strength of  its  experienced  local  staff   and   international   partners.

All Rights Reserved © 2016 | Healthcare Development Holding Company (HDH)

NEWSLETTER

 

 

Subscribe  to  our  newsletter  to  get  the latest  updates  and  company  news

Submitting Form...

The server encountered an error.

Form received.

COMMUNITY-ORIENTED .. SCIENCE-FOCUSED

Highlighting  the  Kingdom’s  leadership vision, LFB Arabia is  the  fruit  of  the first Public Private Partnership (PPP) model  in the pharmaceutical field in the Kingdom for such an  advanced  industry.  It is another strategic partnership with a major  European  player in  the therapeutic protein field, French LFB S.A. The  group  is  the  leading manufacturer of plasma-derived medicinal products in France and 5th worldwide.  It  is  also  among the leading European companies  for  the  development of new-generation  medicinal  products  based  on  biotechnologies.

 

LFB  Arabia  is  partnering with the government of Saudi Arabia to establish a state-of-the art human plasma fractionation  plant.  The  process  of  extracting  human plasma   blood   derivatives  is  the first of its kind in the Kingdom of  Saudi  Arabia  and  the  whole  Muslim  world. This  ambitious plan  benefits  from the vast knowledge of the French LFB  and  allows their expertise to shape each step it takes in the advanced  pharmaceutical  and  biotechnological  field.

ABOUT US

 

 

Healthcare Development Holding  (HDH)  Company was formed in November  2008  with  the  objective  of developing  and  providing a wide range of  healthcare  services  while  focusing on building   local  expertise. HDH plans  to achieve its goals through the strength of its experienced local staff and international partners.

OUR INFO

NEWSLETTER

 

 

Subscribe  to  our  newsletter  to  get  the latest  updates  and  company  news

Submitting Form...

The server encountered an error.

Form received.

All Rights Reserved © 2016

Healthcare Development Holding Company (HDH)

COMMUNITY-ORIENTED .. SCIENCE-FOCUSED

Highlighting  the  Kingdom’s  leadership vision, LFB Arabia is  the  fruit  of  the first Public Private Partnership (PPP) model  in the pharmaceutical field in the Kingdom for such an  advanced  industry.  It is another strategic partnership with a major  European  player in  the therapeutic protein field, French LFB S.A. The  group  is  the  leading manufacturer of plasma-derived medicinal products in France and 5th worldwide.  It  is  also  among the leading European companies  for  the  development of new-generation  medicinal  products  based  on  biotechnologies.

 

LFB  Arabia  is  partnering with the government of Saudi Arabia to establish a state-of-the art human plasma fractionation  plant.  The  process  of  extracting  human plasma   blood   derivatives  is  the first of its kind in the Kingdom of  Saudi  Arabia  and  the  whole  Muslim  world. This  ambitious plan  benefits  from the vast knowledge of the French LFB  and  allows their expertise to shape each step it takes in the advanced  pharmaceutical  and  biotechnological  field.

ABOUT US

 

 

Healthcare Development Holding  (HDH)  Company was formed in November  2008  with  the  objective  of developing  and  providing a wide range of  healthcare  services  while  focusing on building   local  expertise. HDH plans  to achieve its goals through the strength of its experienced local staff and international partners.

OUR INFO

NEWSLETTER

 

 

Subscribe  to  our  newsletter  to  get  the latest  updates  and  company  news

Submitting Form...

The server encountered an error.

Form received.

All Rights Reserved © 2016

Healthcare Development Holding Company (HDH)

ABOUT US

 

 

Healthcare Development Holding  (HDH)  Company was formed in November  2008  with  the  objective  of developing  and  providing a wide range of  healthcare  services  while  focusing on building   local  expertise. HDH plans  to achieve its goals through the strength of  its  experienced  local staff and international partners.

OUR INFO

JEDDAH OFFICE

+966 12 691 8016

+966 12 694 5898

RIYADH OFFICE

+966 11 464 5359

+966 11 466 8195

NEWSLETTER

 

 

Subscribe  to  our  newsletter  to  get  the latest  updates  and  company  news

Submitting Form...

The server encountered an error.

Form received.

All Rights Reserved © 2016

Healthcare Development Holding Company (HDH)